Insights on Clinical Trials

  1. Reducing The Burden Of Patient Retention And Improving Continuity 1/6/2026

    Immunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.

  2. Psychiatric Drug Development Renaissance: With Familiar Risks 1/6/2026

    Emerging psychiatric therapies bring hope, but progress is fragile. Biomarker-driven, mechanism-first approaches help overcome biological, regulatory, and commercial barriers.

  3. Trailblazing Clinical Drug Development In Dermatology 1/6/2026

    AI, imaging, and biomarkers are transforming trials, reducing subjectivity and improving sensitivity while enabling decentralized designs, faster timelines, and more precise insights.

  4. Sales & Operations Planning for Small Teams: Aligning Clinical Supply 1/6/2026

    Small clinical teams don’t fail at S&OP from missing systems—they fail from unclear demand and decisions. Alignment comes from discipline, shared visibility, and acting on reality before timelines slip.

  5. Hybrid Ophthalmic Trials: Splitting Visits Across Home, Hub, And Site 12/23/2025

    Hybrid ophthalmic trials combine in-person and remote visits, boosting patient convenience, reducing site burden, and accelerating timelines while maintaining data quality and compliance.

  6. Vendor Selection Bias: Why Structured Decisions Often Fail 12/22/2025

    Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.

  7. Year-In-Review: Clinical Research Today And Tomorrow 12/10/2025

    As the industry prepares for 2026, sponsors and investors alike face a pivotal moment — one that demands a more deliberate, insight-driven approach to early clinical development.

  8. Europe At A Crossroads: Biotech Investment, Regulation, And Partnership In Real Life 12/10/2025

    Position your biotech for Europe’s next phase by aligning strong science, smart clinical strategy, and the right global partners to navigate funding, regulation, and growth.

  9. 5 Questions That Put Sponsors Back in Control of Bioanalysis Projects 12/9/2025

    Bioanalysis service quality significantly impacts project success. Don't settle for typical CRO claims; demand better technology, pricing transparency, and dedicated partnership.

  10. Overcoming Cell Therapy Design Challenges To Treat AML And Other Life-Threatening Diseases 12/9/2025

    CERo CEO Chris Ehrlich discusses how a focus on safety, robust manufacturing, and key early indicators is rewriting the playbook for future personalized medicine trials.